The Concept of Old Age
- 608.984
- +2.385+0.39%
Happy Healthcare (300562): 1H24 net profit increased year over year, gross margin increased significantly
JPMorgan: As government bond yields rise, believe that China Life Insurance will be a major beneficiary.
Xianle Health (300791): Revenue growth in the Americas remains strong and confidence is sufficient throughout the year
Xianle Health (300791): Endogenous business continues to perform well, expect BF's performance to reduce losses and profits
Xianle Health (300791): Full confidence throughout the year, H2 acceleration can be expected
Lexin Healthcare (300562): Profitability improved markedly, 12-lead electric clothing large single product launched
Goldman Sachs: maintains target price of 15 Hong Kong dollars for New China Life Insurance H-shares and upgrades rating to 'Neutral'.
Xianle Health (300791): Meeting expectations and flexibility
Xianle Health (300791): Overseas business continues to strengthen competitiveness
Xianle Health (300791): BF continues to improve and the target for the whole year progresses steadily
Happy Healthcare (300562): 2024H1 net profit to mother increased, and business adjustments gradually improved
Xianle Health (300791): 24H1 steady growth, BF profit improvement can be expected
Xianle Health (300791): Stable operation in 24Q2 in line with expected incentives and firm employee shareholding targets
Ingenious Home (301061): Outstanding Product Capabilities, Brand Building Begins
Ingenious Home (301061): Tariff risks are expected to be manageable, and the recovery of the US real estate chain can be expected
Kyushu-dori (600998): Leading high-dividend out-of-hospital distribution center with positive ROE
Tomson Beijian (300146): Operating adjustments put pressure on performance
Bank of America Securities reiterated a "buy" rating on China Pacific Insurance (02601) with a target price of HKD 19.9.
Tomson Beijian (300146): 24H1 performance is under pressure to adhere to the strategy of strong technology and strong brand
Tomson Beijian (300146) 2024 Interim Report Review: Iterative Upgrading of High-Base Core Single Products Over the Same Period